A Randomised Trial Evaluating the Effects of the TRPV1 Antagonist SB705498 on Pruritus Induced by Histamine, and Cowhage Challenge in Healthy Volunteers

• Rachel A. Gibson ,

  * E-mail: rachel.a.gibson@gsk.com

  Affiliation Academic Discovery Performance Unit, GlaxoSmithKline, Stevenage, Hertfordshire, United Kingdom

  ⨯
• Jon Robertson,

  Affiliation Quantitative Sciences, GlaxoSmithKline, Stevenage, Hertfordshire, United Kingdom

  ⨯
• Harshna Mistry,

  Affiliation Clinical Pharmacology Science and Study Operations GlaxoSmithKline, Cambridge, Cambridgeshire, United Kingdom

  ⨯
• Stewart McCallum,

  Affiliation Academic Discovery Performance Unit, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America

  ⨯
• Disala Fernando,

  Affiliation Clinical Unit, GlaxoSmithKline, Cambridge, Cambridgeshire, United Kingdom

  ⨯
• Melody Wyres,

  Affiliation Clinical Development, Stiefel, a GSK company, Research Triangle Park, North Carolina, United States of America

  ⨯
• Gil Yosipovitch

  Affiliation Department of Dermatology and Temple Itch Center, Temple University School of Medicine, Philadelphia, Pennsylvania, United States of America

  ⨯